356 related articles for article (PubMed ID: 28625818)
1. Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.
Lynch HN; Zu K; Kennedy EM; Lam T; Liu X; Pizzurro DM; Loftus CT; Rhomberg LR
Environ Int; 2017 Sep; 106():178-206. PubMed ID: 28625818
[TBL] [Abstract][Full Text] [Related]
2. Bayesian benchmark dose analysis for inorganic arsenic in drinking water associated with bladder and lung cancer using epidemiological data.
Shao K; Zhou Z; Xun P; Cohen SM
Toxicology; 2021 May; 455():152752. PubMed ID: 33741492
[TBL] [Abstract][Full Text] [Related]
3. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
Tsuji JS; Alexander DD; Perez V; Mink PJ
Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
[TBL] [Abstract][Full Text] [Related]
4. Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.
Mendez WM; Eftim S; Cohen J; Warren I; Cowden J; Lee JS; Sams R
J Expo Sci Environ Epidemiol; 2017 May; 27(3):235-243. PubMed ID: 27901016
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the carcinogenicity of inorganic arsenic.
Cohen SM; Arnold LL; Beck BD; Lewis AS; Eldan M
Crit Rev Toxicol; 2013 Oct; 43(9):711-52. PubMed ID: 24040994
[TBL] [Abstract][Full Text] [Related]
6. Low-dose risk assessment for arsenic: a meta-analysis approach.
Begum M; Horowitz J; Hossain MI
Asia Pac J Public Health; 2015 Mar; 27(2):NP20-35. PubMed ID: 23188879
[TBL] [Abstract][Full Text] [Related]
7. Roxarsone, inorganic arsenic, and other arsenic species in chicken: a U.S.-based market basket sample.
Nachman KE; Baron PA; Raber G; Francesconi KA; Navas-Acien A; Love DC
Environ Health Perspect; 2013 Jul; 121(7):818-24. PubMed ID: 23694900
[TBL] [Abstract][Full Text] [Related]
8. Considerations in deriving quantitative cancer criteria for inorganic arsenic exposure via inhalation.
Lewis AS; Beyer LA; Zu K
Environ Int; 2015 Jan; 74():258-73. PubMed ID: 25454243
[TBL] [Abstract][Full Text] [Related]
9. Arsenic exposure in US public and domestic drinking water supplies: a comparative risk assessment.
Kumar A; Adak P; Gurian PL; Lockwood JR
J Expo Sci Environ Epidemiol; 2010 May; 20(3):245-54. PubMed ID: 19401722
[TBL] [Abstract][Full Text] [Related]
10. Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan.
Brown KG; Chen CJ
Risk Anal; 1995 Aug; 15(4):475-84. PubMed ID: 7480947
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a Physiologically Based Pharmacokinetic (PBPK) Model for Inorganic Arsenic Exposure Using Data from Two Diverse Human Populations.
El-Masri HA; Hong T; Henning C; Mendez W; Hudgens EE; Thomas DJ; Lee JS
Environ Health Perspect; 2018 Jul; 126(7):077004. PubMed ID: 30024383
[TBL] [Abstract][Full Text] [Related]
12. Discontinuity in the cancer slope factor as it passes from high to low exposure levels--arsenic in the BFD-endemic area.
Lamm SH; Robbins S; Chen R; Lu J; Goodrich B; Feinleib M
Toxicology; 2014 Dec; 326():25-35. PubMed ID: 25241138
[TBL] [Abstract][Full Text] [Related]
13. Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence.
Christoforidou EP; Riza E; Kales SN; Hadjistavrou K; Stoltidi M; Kastania AN; Linos A
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(14):1764-75. PubMed ID: 24007431
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cancer risk and environmental levels of arsenic in New Hampshire.
Karagas MR; Stukel TA; Tosteson TD
Int J Hyg Environ Health; 2002 Mar; 205(1-2):85-94. PubMed ID: 12018020
[TBL] [Abstract][Full Text] [Related]
15. Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence.
Saint-Jacques N; Parker L; Brown P; Dummer TJ
Environ Health; 2014 Jun; 13():44. PubMed ID: 24889821
[TBL] [Abstract][Full Text] [Related]
16. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
[TBL] [Abstract][Full Text] [Related]
17. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
Mink PJ; Alexander DD; Barraj LM; Kelsh MA; Tsuji JS
Regul Toxicol Pharmacol; 2008 Dec; 52(3):299-310. PubMed ID: 18783726
[TBL] [Abstract][Full Text] [Related]
18. Association of low-level arsenic exposure in drinking water with cardiovascular disease: a systematic review and risk assessment.
Tsuji JS; Perez V; Garry MR; Alexander DD
Toxicology; 2014 Sep; 323():78-94. PubMed ID: 24953689
[TBL] [Abstract][Full Text] [Related]
19. Dose-response for assessing the cancer risk of inorganic arsenic in drinking water: the scientific basis for use of a threshold approach.
Tsuji JS; Chang ET; Gentry PR; Clewell HJ; Boffetta P; Cohen SM
Crit Rev Toxicol; 2019 Jan; 49(1):36-84. PubMed ID: 30932726
[TBL] [Abstract][Full Text] [Related]
20. Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic.
Gibb H; Haver C; Gaylor D; Ramasamy S; Lee JS; Lobdell D; Wade T; Chen C; White P; Sams R
Environ Health Perspect; 2011 Mar; 119(3):284-90. PubMed ID: 21030336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
